Asia's in vitro diagnostics (IVD) market - global microcosm or special case?
This article was originally published in Clinica
Executive Summary
The Asian IVD market breaks down very much along global lines with immunodiagnostics, clinical chemistry and diabetes tests contributing the lion's share - 34%, 21% and 8% respectively in Asia and 34%, 17% and 7% globally